超越视野:原发性开角型青光眼心理困扰的心理社会决定因素
这项前瞻性横断面研究纳入300例原发性开角型青光眼患者,采用经验证的量表评估心理困扰、自我效能、社会支持和视功能相关生活质量。多变量分析显示,自我效能和社会支持与心理困扰独立相关,且存在交互效应,提示可干预的心理社会因素在患者情绪健康中起重要作用。
要点
- 自我效能和社会支持是心理困扰的独立预测因素,超越传统临床指标。
- 视功能相关生活质量与社会支持、低社会支持与低自我效能间存在交互效应。
- 整合心理社会需求的照护模式可能有助于减轻青光眼患者心理困扰。
核心结论
- 心理社会变量是原发性开角型青光眼患者心理困扰的重要且相互关联的预测因素,超越传统临床指标所能捕获的范围。
- 可干预的心理社会因素在塑造患者情绪健康方面具有关键作用。
- 针对心理社会需求的整合照护模式是减轻心理困扰和改善青光眼结局的重要机会。
研究设计与样本
- 前瞻性横断面研究,于2022年9月至2023年8月从Duke Eye Center青光眼门诊招募300例原发性开角型青光眼患者。
- 参与者完成医院焦虑抑郁量表(HADS)、慢性病管理自我效能量表(SE-6)、改良医学结局研究社会支持调查量表(MOS-8)和国家眼科研究所视功能问卷(NEI VFQ-9)。
- 临床数据从电子健康记录中提取,采用单变量和多变量泊松回归模型评估心理困扰与心理社会/临床变量的关联,包括交互效应。
主要发现
- 队列平均年龄68.4岁(52%女性),81%为白人,15%为黑人/非裔美国人。
- HADS总平均分9.21(SD=6.28),55例参与者(18%)报告显著心理困扰(HADS>14)。
- 单变量分析中,较差的视功能相关生活质量(RR=0.78,P<.001)、较弱的社会支持(RR=0.78,P<.001)和较低的自我效能(RR=0.74,P<.001)均与更大的心理困扰相关。
- 多变量分析中,自我效能(RR=0.82,P<.001)和社会支持(RR=0.83,P<.001)仍独立相关。
- 视功能相关生活质量与社会支持(RR=0.91,P<.001)、低社会支持与低自我效能(RR=1.06,P=.005)之间存在显著交互效应。
关键数值与推荐
- 心理困扰以HADS测量,显著心理困扰定义为HADS>14。
- 单变量分析中视功能相关生活质量RR=0.78(P<.001)、社会支持RR=0.78(P<.001)、自我效能RR=0.74(P<.001)。
- 多变量分析中自我效能RR=0.82(P<.001)、社会支持RR=0.83(P<.001)。
- 交互效应:视功能相关生活质量与社会支持RR=0.91(P<.001),低社会支持与低自我效能RR=1.06(P=.005)。
临床怎么用
- 在青光眼管理中应评估患者的自我效能和社会支持等心理社会因素,以识别心理困扰高风险个体。
- 可考虑将心理社会支持纳入整合照护模式,以减轻患者心理困扰并改善结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify psychosocial and clinical predictors of psychological distress in patients with primary open-angle glaucoma (POAG). DESIGN: Prospective cross-sectional study. PARTICIPANTS: 300 patients with a diagnosis of POAG were recruited from the Duke Eye Center glaucoma clinics between September 2022 and August 2023. METHODS: Participants completed validated self-report questionnaires, including the Hospital Anxiety and Depression Scale (HADS, psychological distress), Self-Efficacy for Managing Chronic Disease Scale (SE-6, self-efficacy), Modified Medical Outcomes Study Social Support Survey Scale (MOS-8, social support), and the National Eye Institute Visual Function Questionnaire Scale (NEI VFQ-9, vision-related quality of life [QoL]). Clinical data were abstracted from electronic health records. Univariable and multivariable Poisson regression models assessed associations between distress and psychosocial / clinical variables, including interaction effects. Risk ratios (RRs) and P-values were reported. MAIN OUTCOME MEASURES: Psychological distress measured by HADS. RESULTS: The cohort had a mean age of 68.4 years (52% female), with 81% identifying as White and 15% as Black/African American. Mean total HADS score was 9.21 (SD = 6.28), with 55 participants (18%) reporting significant psychological distress (HADS > 14). Younger age, female sex, lower socioeconomic indicators (education, income, employment status), and clinical markers were also found to be significant predictors of distress in univariable analyses, with age remaining significant in multivariable analyses. In univariable models, poorer vision-related QoL (RR = 0.78, P < .001), weaker social support (RR = 0.78, P < .001), and lower self-efficacy (RR = 0.74, P < .001) were all associated with greater distress. In multivariable analyses, self-efficacy (RR = 0.82, P < .001) and social support (RR = 0.83, P < .001) remained independently associated. Significant interaction effects were estimated between vision-related QoL and social support (RR = 0.91, P < .001), and low social support and low self-efficacy (RR = 1.06, P = .005), indicating combinations of psychosocial strengths and vulnerabilities may shape distress risk. CONCLUSIONS: Psychosocial variables are significant and interrelated predictors of distress in POAG, beyond what is captured by traditional clinical metrics. These findings underscore the critical role of modifiable psychosocial factors in shaping patients' emotional well-being. Integrated care models to address psychosocial needs represents an important opportunity to mitigate distress and improve glaucoma outcomes.
引用
- Vaidyanathan A, Baek Y, Ekeh L, et al. Beyond the Visual Field: Psychosocial Determinants of Psychological Distress in Primary Open-Angle Glaucoma. Am J Ophthalmol. 2026. PMID: 42575406. doi:10.1016/j.ajo.2026.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。